Harman v. Lyphomed, Incorporated

945 F.2d 969
CourtCourt of Appeals for the Seventh Circuit
DecidedOctober 30, 1991
Docket90-2032
StatusPublished

This text of 945 F.2d 969 (Harman v. Lyphomed, Incorporated) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Harman v. Lyphomed, Incorporated, 945 F.2d 969 (7th Cir. 1991).

Opinion

945 F.2d 969

Fed. Sec. L. Rep. P 96,277
Sarah HARMAN, Samuel Golden, Emery Sugar, et al., Plaintiffs-Appellees,
v.
LYPHOMED, INCORPORATED, John N. Kapoor, Neil Gurwara, et
al., Defendants.
Appeal of ROBERT S. ATKINS AND ASSOCIATES, Robert D.
Allison, Stull, Stull & Brody, Much, Shelist, Freed
Denenberg, Ament & Eiger, Berger & Montague, Barrack, Rodos
& Bacine, Milberg, Weiss, Bershad, Specthrie & Lerach,
Plaintiff Class Counsel-Appellants.

No. 90-2032.

United States Court of Appeals,
Seventh Circuit.

Argued June 10, 1991.
Decided Oct. 9, 1991.
As Amended Oct. 30, 1991.

Sarah Harman, Samuel Golden, Emery Sugar, Emil Sugar, Joseph Harris and Barbara Kay Ament, pro se.

John W. Rotunno, William R. Carney, John B. Bitner, Larry L. Thompson, Bell, Boyd & Lloyd, Chicago, Ill., for defendants.

Robert D. Allison, pro se.

Michael P. Malakoff, argued, Berger, Kapetan, Malakoff & Myers, Pittsburgh, Pa., for appellant Robert D. Allison.

Michael J. Freed, Michael B. Hyman, Much, Shelist, Freed, Denenberg, Ament & Eiger, Chicago, Ill., for appellants.

Carole A. Broderick, Berger & Montague, pro se.

Leonard Barrack, Barrack, Rodos & Bacine, pro se.

David J. Bershad, Jerome Congress, Milberg, Weiss, Bershad, Specthrie & Lerach, pro se.

Geoffrey P. Miller, Chicago, Ill., for Milberg, Weiss, Bershad, Specthrie & Lerach.

Mark L. Levine, Kirkland & Ellis, Chicago, Ill., for appellant Stull, Stull & Brody.

Jules Brody, Stull, Stull & Brody, pro se.

Robert S. Atkins, pro se.

Robert E. Williams, Coleman & Associates, Geoffrey P. Miller, Chicago, Ill., for appellant Robert S. Atkins and Associates.

Before CUDAHY, COFFEY and FLAUM, Circuit Judges.

CUDAHY, Circuit Judge.

Out of a $10.4 million settlement fund, the district court awarded plaintiffs' counsel $950,000 in fees and $121,277 in expenses, the total of which--$1,071,277--is about 10.3 percent of the fund.1 On the attorneys' motion for reconsideration, the court increased the fees to $1,050,000, plus the $121,277 in expenses. Counsel had requested $2,997,000 in fees and $131,900 in expenses. In making the award, the district court relied on the widely accepted lodestar-and-multiplier method and refused to adopt the percentage-of-the-fund approach. The court also declined to award a multiplier. On appeal the attorneys suggest adoption of the percentage-of-the-fund method as a rule of law in common fund cases. They also argue that the district court's methodology for computing the lodestar figure was improper, that the district court used an improper average for the attorneys' claimed hourly rates, that class counsel is entitled to a multiplier and that the court improperly denied expenses for computer-assisted legal research.

I.

The underlying litigation was a class action that consolidated several individual suits and a derivative suit against Lyphomed for alleged violations of section 10(b) of the Securities and Exchange Act of 1934, 15 U.S.C. § 78j(b) (1988). The complaint alleged fraudulent disclosures relating to product development and quality control. In 1987 the Food and Drug Administration was investigating alleged deficiencies in the firm's quality control measures and had alerted the company to possible violations of the Food, Drug and Cosmetic Act. This case was filed in January 1988. Discovery ensued, substantial settlement negotiations began in November 1988, a memorandum of understanding was reached in April 1989 and the parties entered a settlement stipulation in June 1989. On December 21, 1989, the district court approved the $10.4 million settlement.

Plaintiffs' counsel then sought fees and expenses from the common fund. In their December 18, 1989, request, counsel asked for $2,997,000 in fees, or just under thirty percent of the total. They also calculated a lodestar of $1,376,423 and suggested a multiplier of 2.177, yielding the same total. The attorneys claimed that the amount was fair and reasonable and that it did not exceed the thirty percent cap promised to class members. Counsel also requested $131,899.93 in expenses. Documentation of the fee request included summaries of expended time, listings of current hourly rates, work descriptions, biographies, schedules of expenses and depositions from other attorneys attesting to the rates. The request covered sixty-one attorneys--thirty-one partners, twenty-eight associates and two student interns--representing four Chicago, four New York and two Philadelphia law firms.

The district court's decision of February 27, 1990, 734 F.Supp. 294, begins with four assumptions. The first is that the substantive reforms that took place at Lyphomed were the result of the FDA enforcement action and not the class action. Second, the court believed that the settlement was not the "extraordinary damage recovery" claimed by counsel. Third, the court considered it a strike against counsel that the settlement had been structured in a way that might hurt class members holding Lyphomed stock; whether true or not, the court thought it counsel's duty to mention this aspect of the settlement. Finally, the court observed that the case "did not involve protracted litigation," although discovery was somewhat vigorously resisted by the defense.

Reviewing the time and rate submissions, the court clearly suspected overbilling. The order observes that "a large number of attorneys [are] billing a substantial amount of time and it appears that such circumstances resulted in otherwise unnecessary duplication of effort." Order at 4. Further, the court requested that counsel provide more detailed billing data for three sample periods of the litigation: preparation of the class certification brief; final settlement approval; and court appearances for twenty-six status and motion calls. The court remained somewhat dissatisfied with the submissions but calculated needed subtotals and totals on its own.

To determine the award, the court first calculated a lodestar. Examining the first of the three sample periods, the judge concluded that class certification preparation showed that "much of counsel's bill consists of unnecessary duplication of work brought about by having an excessive number of attorneys involved in the case." Order at 7. The judge reduced the requested $58,591 to $30,000. The court then examined the submissions relating to the memorandum in support of final settlement and decided that the $40,441 billed was overstated; he granted $20,000 as "more than adequate compensation for the memorandum." Id. Finally, the court detected overbilling in the $24,406 requested for ninety-nine hours of court appearance involving twenty-six status and motion calls. Included in the request were court appearances on dates for which the docket showed no court activity.2

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Alyeska Pipeline Service Co. v. Wilderness Society
421 U.S. 240 (Supreme Court, 1975)
Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Anita Kirchoff and William Kirchoff v. Michael Flynn
786 F.2d 320 (Seventh Circuit, 1986)
Stephen Ustrak v. James W. Fairman
851 F.2d 983 (Seventh Circuit, 1988)
In Re Cenco Inc. Securities Litigation
519 F. Supp. 322 (N.D. Illinois, 1981)
Harman v. Lyphomed, Inc.
734 F. Supp. 294 (N.D. Illinois, 1990)
In Re Union Carbide Consumer Prod. Bus. SEC. Lit.
724 F. Supp. 160 (S.D. New York, 1989)
In Re Activision Securities Litigation
723 F. Supp. 1373 (N.D. California, 1989)
In re Folding Carton Antitrust Litigation
84 F.R.D. 245 (N.D. Illinois, 1979)
In re Fine Paper Antitrust Litigation
751 F.2d 562 (Third Circuit, 1984)
Skelton v. General Motors Corp.
860 F.2d 250 (Seventh Circuit, 1988)
Paul, Johnson, Alston & Hunt v. Graulty
886 F.2d 268 (Ninth Circuit, 1989)
Florida v. Dunne
915 F.2d 542 (Ninth Circuit, 1990)
Harman v. Lyphomed, Inc.
945 F.2d 969 (Seventh Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
945 F.2d 969, Counsel Stack Legal Research, https://law.counselstack.com/opinion/harman-v-lyphomed-incorporated-ca7-1991.